Quantum News Briefs November 21: Quantum Computing, Inc. Announces Second Purchase Order for TFLN Photonic Chip Foundry from UT Austin • Quantum Rings Achieves Breakthrough in Large-Scale Quantum Circuit Simulation • Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform • Lightsynq Comes Out of Stealth with $18M in Series A Funding to Scale Quantum Computing •
Quantum-Si Expands Collaboration with SkyWater to Develop New Chip Production Process Critical for Groundbreaking New Proteomics Platform
Quantum-Si Incorporated (Nasdaq: QSI), The Protein Sequencing Company and SkyWater Technology (NASDAQ: SKYT), the trusted technology realization partner, have announced they will jointly expand their relationship to support the development of Proteus, Quantum-Si’s next-generation platform designed to transform proteomic research. The expanded collaboration will develop the consumable for Proteus that will enable simultaneous large factor, protein sequencing with unparalleled accuracy.
Quantum-Si and SkyWater began partnering in 2021 on the first-generation Platinum® platform and announced transition to support production in the second quarter of 2024. SkyWater will continue to supply the consumables for the Platinum Pro product as the two companies expand their engagement to support commercialization of Proteus.
This cutting-edge solution is set to redefine proteomics with unprecedented output per sample, application flexibility and automation. By combining Quantum-Si’s expertise in biotechnology with SkyWater’s Technology as a Service (TaaS) manufacturing capabilities, the collaboration is poised to drive significant advancements in protein sequencing and to the field of proteomics.
Leveraging its custom process development and robust manufacturing capabilities, SkyWater enables the unique technological needs of microfluidic biomedical devices from proof of concept to final qualification. Embracing a TaaS model, SkyWater facilitates early collaboration with system engineers and device designers, developing technology within a production environment. This approach expedites time-to-market, ensures quality from inception, and seamlessly scales to meet volume production demands.
SkyWater holds certification to the ISO 13485 Quality Standard for Medical Devices, affirming its ability to support the design, development, and fabrication of biomedical applications.
Lightsynq Comes Out of Stealth with $18M in Series A Funding to Scale Quantum Computing
Lightsynq Technologies Inc., a startup developing quantum interconnect technology solutions for commercial use, announced it has raised approximately $18 million in Series A funding. The round was led by Cerberus Ventures, the venture investing platform of Cerberus Capital Management, L.P. (Cerberus), with participation from Murata Electronics North America Inc., IAG Capital Partners, Safar Partners, QVT, Element Six and In-Q-Tel (IQT).
Founded by former Harvard quantum networking experts and Amazon Web Services (AWS) Center for Quantum Networking leaders, Dr. Mihir Bhaskar (CEO), Dr. Bart Machielse (CTO) and Dr. David Levonian (CPO), Lightsynq is developing state-of-the-art optical quantum interconnects that enable hardware providers to link quantum processors. Lightsynq’s technology will help solve the core challenge of linking together individual quantum computers into a broader network, overcoming the limitations of single system scaling.
The funds will be used to build Lightsynq’s quantum interconnect technology, which is based on color centers in diamond photonic devices, combining a leading quantum networking platform with scalable photonic fabrication. This proprietary solution will provide a pathway to foundry-scale production of quantum interconnects, enabling more usable qubits across networks and accelerating wider industrial and commercial applications of quantum computing.
